The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)*

Chen, Robert T; Carbery, Baevin; Mac, Lisa; Chapman, Louisa; Condit, Richard C.; Excler, Jean-Louis; Gurwith, Marc; Hendry, Michael; Khan, Arifa S.; Khuri-Bulos, Najwa; Klug, Bettina; Robertson, Jim S; Seligman, Stephen J.; Sheets, Rebecca; Williamson, Anna-Lise

doi:10.1016/j.vaccine.2014.09.035

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)*

1 1 2015
By Chen, Robert T ; Carbery, Baevin ; Mac, Lisa ; ...
http://dx.doi.org/10.1016/j.vaccine.2014.09.035
Source: Vaccine. 33(1):73-75

[PDF-80.67 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Vaccine
Personal Author:

Chen, Robert T ; Carbery, Baevin ; Mac, Lisa ; Chapman, Louisa ; Condit, Richard C. ; ... More +

Chen, Robert T ; Carbery, Baevin ; Mac, Lisa ; Chapman, Louisa ; Condit, Richard C. ; Excler, Jean-Louis ; Gurwith, Marc ; Hendry, Michael ; Khan, Arifa S. ; Khuri-Bulos, Najwa ; Klug, Bettina ; Robertson, Jim S ; Seligman, Stephen J. ; Sheets, Rebecca ; Williamson, Anna-Lise Less -
Description:

Recombinant viral vectors provide an effective means for heterologous antigen expression in vivo and thus represent promising platforms for developing novel vaccines against human pathogens from Ebola to tuberculosis. An increasing number of candidate viral vector vaccines are entering human clinical trials. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to improve our ability to anticipate potential safety issues and meaningfully assess or interpret safety data, thereby facilitating greater public acceptance when licensed.
Subjects:

[+]

Article Clinical Trials As Topic Drug-Related Side Effects And Adverse Reactions Drug Carriers Genetic Vectors Humans International Cooperation Vaccines, Synthetic Viral Vaccines
Source:

Vaccine. 33(1):73-75
Pubmed ID:

25305565
Pubmed Central ID:

PMC4568939
Document Type:

Journal Article
Funding:

CC999999/Intramural CDC HHSUnited States/
Volume:

33
Issue:

1
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha256:23bc374a69c9af80861d52baec6a6b2e959304c15ef59e81f93776af4eb7a135
Download URL:

https://stacks.cdc.gov/view/cdc/34287/cdc_34287_DS1.pdf
File Type:

nihms720669.nxml

xml

More +